伊玛提克斯

最新新闻

• Mizuho Securities Maintains Immatics(IMTX.US) With Buy Rating, Maintains Target Price $25
  \u5e02\u573a\u8d44\u8baf · 2026/8/20
• 评级变动
  TD Cowen Maintains Immatics(IMTX.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/19
• 评级变动
  Analysts Conflicted on These Healthcare Names: Siemens Healthineers AG (OtherSEMHF), Immatics (IMTX) and Aardvark Therapeutics, Inc. (AARD)
  TipRanks · 2026/3/24
• 评级变动
  Goldman Sachs Maintains Immatics(IMTX.US) With Buy Rating, Raises Target Price to $12.2
  \u5e02\u573a\u8d44\u8baf · 2026/5/13
• Goldman Sachs Maintains Immatics(IMTX.US) With Buy Rating, Cuts Target Price to $11.8
  \u5e02\u573a\u8d44\u8baf · 2026/8/19
• Jefferies Maintains Immatics(IMTX.US) With Buy Rating, Cuts Target Price to $17
  \u5e02\u573a\u8d44\u8baf · 2026/8/26
• 评级变动
  Analysts Offer Insights on Healthcare Companies: LifeMD (LFMD), Immatics (IMTX) and BrightSpring Health Services, Inc. (BTSG)
  TipRanks · 2026/3/16
• 评级变动
  Mizuho Securities Maintains Immatics(IMTX.US) With Buy Rating, Raises Target Price to $23
  \u5e02\u573a\u8d44\u8baf · 2025/11/19
• 评级变动
  Mizuho Securities Maintains Immatics(IMTX.US) With Buy Rating, Announces Target Price $25
  \u5e02\u573a\u8d44\u8baf · 2026/2/19
• 评级变动
  Jefferies Initiates Immatics(IMTX.US) With Buy Rating, Announces Target Price $18
  \u5e02\u573a\u8d44\u8baf · 2026/3/16
• Earnings Flash (IMTX) Immatics Posts Q2 Revenue 9.1M Euros, Vs. FactSet Est of 10.4M Euros
  MT Newswires · 2026/8/18
• BofA Securities Maintains Immatics(IMTX.US) With Buy Rating, Maintains Target Price $17
  \u5e02\u573a\u8d44\u8baf · 2026/8/19
• 评级变动
  TD Cowen Initiates Immatics(IMTX.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/4/28
• 评级变动
  BofA Securities Maintains Immatics(IMTX.US) With Buy Rating, Raises Target Price to $17
  \u5e02\u573a\u8d44\u8baf · 2026/1/6
• 评级变动
  Chardan Capital Maintains Immatics(IMTX.US) With Buy Rating, Maintains Target Price $25
  \u5e02\u573a\u8d44\u8baf · 2026/5/20
• 评级变动
  Mizuho Securities Maintains Immatics(IMTX.US) With Buy Rating, Maintains Target Price $23
  \u5e02\u573a\u8d44\u8baf · 2025/12/8
• 评级变动
  Guggenheim Maintains Immatics(IMTX.US) With Buy Rating, Maintains Target Price $19
  \u5e02\u573a\u8d44\u8baf · 2026/5/13
• 评级变动
  Clear Street Initiates Immatics(IMTX.US) With Buy Rating, Announces Target Price $18
  \u5e02\u573a\u8d44\u8baf · 2025/12/12
• 评级变动
  Guggenheim Maintains Immatics(IMTX.US) With Buy Rating, Raises Target Price to $19
  \u5e02\u573a\u8d44\u8baf · 2025/11/18
• 评级变动
  Leerink Partners Maintains Immatics(IMTX.US) With Buy Rating, Announces Target Price $17
  \u5e02\u573a\u8d44\u8baf · 2026/3/6

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。